Sulfonamides and Trimethoprim

Intro & MOA - Folate Foes

• Sulfonamides & Trimethoprim: Key synthetic antimicrobials. Bacteriostatic individually.
• MOA: Synergistic sequential blockade of bacterial folic acid synthesis. Humans utilize pre-formed dietary folate, ensuring selective toxicity.
  • Sulfonamides (e.g., Sulfamethoxazole):
    • PABA (para-aminobenzoic acid) structural analogues.
    • Competitively inhibit bacterial Dihydropteroate Synthase.
    • Prevent PABA $\rightarrow$ Dihydropteroic acid.
  • Trimethoprim:
    • Potent inhibitor of bacterial Dihydrofolate Reductase (DHFR).
    • Prevents DHF (Dihydrofolic acid) $\rightarrow$ THF (Tetrahydrofolic acid - active form).
• 📌 Mnemonic: Sulfa drugs Stop PABA at the Start; Trimethoprim Targets DHFR Downstream.

⭐ Co-trimoxazole (TMP-SMX combination) exhibits synergistic bactericidal activity due to this dual blockade, broadening spectrum and reducing resistance development.

Pharmacokinetics - Dynamic Duo's Journey

• Sulfonamides (e.g., Sulfamethoxazole - SMX):
  • Absorption: Good orally.
  • Distribution: Variable protein binding (↑drug interactions: bilirubin, warfarin); crosses placenta.
  • Metabolism: Hepatic acetylation (📌 Slow acetylators ↑toxicity; metabolite → crystalluria).
  • Excretion: Renal (filtration, secretion); adjust dose in renal failure.
• Trimethoprim (TMP):
  • Absorption: Good orally.
  • Distribution: Wide; excellent tissue penetration (CSF, prostate); lipophilic.
  • Metabolism: Hepatic (minor).
  • Excretion: Renal (mostly unchanged); adjust dose in renal failure.
• Co-trimoxazole (SMX + TMP):
  • Pharmacokinetic match: Similar $T_{1/2}$ (~10-12h) allows combined dosing.
  • Dosing SMX 5:TMP 1 → plasma conc. 20:1 for synergy.

  ⭐ Sulfonamides displace bilirubin from albumin → ↑risk of kernicterus in neonates.

Clinical Spectrum - Germ Warfare Gurus

Co-trimoxazole (TMP-SMX): A broad-spectrum agent. Key uses:

• Urinary Tract Infections (UTIs): Uncomplicated & complicated.
• Pneumocystis jirovecii Pneumonia (PJP):
  • Treatment: Drug of Choice (DOC).
  • Prophylaxis: Immunocompromised (e.g., HIV CD4 < 200/mm³).
• Nocardiosis: DOC.
• Toxoplasmosis: Alternative for cerebral toxo in AIDS.
• Listeriosis: Alternative, especially if penicillin-allergic.
• Others: Shigellosis, Salmonella (select cases), Stenotrophomonas maltophilia.

Other Sulfonamides/Related:

• Sulfasalazine: IBD (UC, Crohn's), Rheumatoid Arthritis.
• Silver sulfadiazine: Topical for burn infections.
• Sulfacetamide: Ophthalmic for bacterial conjunctivitis.
• Pyrimethamine-Sulfadoxine: Malaria (limited by resistance).

⭐ Co-trimoxazole is the Drug of Choice (DOC) for Pneumocystis jirovecii pneumonia (PJP) treatment/prophylaxis and Nocardiosis.

Adverse Effects & Cautions - The Watch-Out List

• Hypersensitivity: Rashes, fever, photosensitivity. Severe: Stevens-Johnson Syndrome (SJS), TEN.
• Crystalluria: (Sulfonamides) Prevent with hydration. Risk with older agents.
• Hematologic:
  • Sulfonamides: Hemolytic anemia (G6PD deficiency), agranulocytosis.
  • Trimethoprim: Megaloblastic anemia (folate deficiency), leukopenia.
• Kernicterus: (Sulfonamides) In newborns; bilirubin displacement from albumin.

  ⭐ Sulfonamides: Contraindicated in neonates (< 2 months) & late pregnancy due to kernicterus risk.

• Trimethoprim Specific: Hyperkalemia (monitor K+), GI upset.
• 📌 Mnemonic (SULFA ADRs): SJS, Skin, Solubility low (crystalluria), Serum albumin displacement, Anemia (G6PD).
• Contraindications:
  • Infants < 2 months (Sulfonamides).
  • Pregnancy (Sulfonamides near term; Trimethoprim 1st trimester).
  • G6PD deficiency (Sulfonamides).
• Drug Interactions (↑ effect of): Warfarin, Methotrexate, Phenytoin. (Sulfonylureas with Sulfonamides).

High‑Yield Points - ⚡ Biggest Takeaways

• Sulfonamides (Dihydropteroate synthase inhibitor) & Trimethoprim (Dihydrofolate reductase inhibitor) cause sequential folate blockade.
• Co-trimoxazole (TMP-SMX) treats UTIs, PJP, Nocardiosis, Toxoplasmosis.
• Sulfonamide ADRs: Hypersensitivity, SJS, crystalluria, G6PD hemolysis, kernicterus.
• Trimethoprim ADRs: Megaloblastic anemia, leukopenia, hyperkalemia.
• Resistance: Altered enzymes, ↑PABA, ↓permeability.
• Contraindications: Newborns, late pregnancy (kernicterus); G6PD deficiency (sulfonamides).
• Key precaution: Hydration with sulfonamides to prevent crystalluria.